Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A primary or metastatic malignant tumor involving the leptomeninges.
Biomarker and diagnostic research for malignant leptomeningeal tumor has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
182 publications have been identified in PubMed for malignant leptomeningeal tumor. Research spans Basic Science / Preclinical (29%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (12%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 52 | 29% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:01 PM UTC
Research summaries |
46 |
25% |
Testing and diagnosis research | 22 | 12% |
Disease patterns and progression | 21 | 12% |
Clinical study results | 14 | 8% |
Patient case studies | 12 | 7% |
New treatment approaches | 11 | 6% |
Other research | 4 | 2% |
Nieto P (2026). [PMID: 41794040](https://pubmed.ncbi.nlm.nih.gov/41794040/). *Cell Rep Med*. [Basic Science / Preclinical]
Kanaya N (2026). [PMID: 41260953](https://pubmed.ncbi.nlm.nih.gov/41260953/). *Trends Mol Med*. [Review / Meta-Analysis]
Aggarwal A (2026). [PMID: 41476144](https://pubmed.ncbi.nlm.nih.gov/41476144/). *Neuro Oncol*. [Basic Science / Preclinical]
Yang C (2026). [PMID: 41287477](https://pubmed.ncbi.nlm.nih.gov/41287477/). *Neuro Oncol*. [Diagnostic / Biomarker]
Basaran AE (2026). [PMID: 41632362](https://pubmed.ncbi.nlm.nih.gov/41632362/). *J Neurooncol*. [Basic Science / Preclinical]
Shiraki Y (2026). [PMID: 41213602](https://pubmed.ncbi.nlm.nih.gov/41213602/). *Brain pathology (Zurich, Switzerland)*. [Epidemiology / Natural History]
Zhang H (2026). [PMID: 42262659](https://pubmed.ncbi.nlm.nih.gov/42262659/). *Cancer Metastasis Rev*. [Review / Meta-Analysis]
Youngblood MW (2026). [PMID: 41680157](https://pubmed.ncbi.nlm.nih.gov/41680157/). *Nat Commun*. [Basic Science / Preclinical]
Patra P (2026). [PMID: 42003166](https://pubmed.ncbi.nlm.nih.gov/42003166/). *Pigment Cell Melanoma Res*. [Review / Meta-Analysis]
Shah KH (2026). [PMID: 42065770](https://pubmed.ncbi.nlm.nih.gov/42065770/). *Childs Nerv Syst*. [Review / Meta-Analysis]